BiotechTube
Home/Treeway/Bernard Muller
BM

Bernard Muller

Co-Founder

Treeway

Therapeutic Areas

Amyotrophic Lateral Sclerosis (ALS)Alzheimer's DiseaseNeurodegenerative Diseases

Treeway Pipeline

DrugIndicationPhase
TW001Alzheimer's DiseasePhase 2
Combination treatmentAlzheimer's DiseasePhase 2
New targets programALSPreclinical
TW002Not SpecifiedNot Specified

Leadership Team at Treeway

RJ
Robbert Jan Stuit
Co-Founder
ID
Inez de Greef
CEO
View full Treeway profile